Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Nora

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Heart Journal|May 22, 2019
Statin therapy increases lipoprotein(a) levelsSotirios Tsimikas, Philip L S M Gordts, Chelsea Nora, et al.
Diabetes|September 26, 2022
Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in ObesityBastian Ramms, Dennis P Pollow, Han Zhu, et al.
Scientific Reports|August 9, 2018
Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-SulfotransferaseDavid F Thieker, Yongmei Xu, Digantkumar Chapla, et al.
Scientific Reports|June 10, 2020
Author Correction: Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-SulfotransferaseDavid F Thieker, Yongmei Xu, Digantkumar Chapla, et al.
Journal of Lipid Research|May 17, 2019
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearanceBastian Ramms, Sohan Patel, Chelsea Nora, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 InfectionDaniel R Sandoval, Thomas Mandel Clausen, Chelsea Nora, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Heart Journal|May 22, 2019
Statin therapy increases lipoprotein(a) levelsSotirios Tsimikas, Philip L S M Gordts, Chelsea Nora, et al.
Diabetes|September 26, 2022
Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in ObesityBastian Ramms, Dennis P Pollow, Han Zhu, et al.
Scientific Reports|August 9, 2018
Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-SulfotransferaseDavid F Thieker, Yongmei Xu, Digantkumar Chapla, et al.
Scientific Reports|June 10, 2020
Author Correction: Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-SulfotransferaseDavid F Thieker, Yongmei Xu, Digantkumar Chapla, et al.
Journal of Lipid Research|May 17, 2019
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearanceBastian Ramms, Sohan Patel, Chelsea Nora, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 InfectionDaniel R Sandoval, Thomas Mandel Clausen, Chelsea Nora, et al.
Pageof 1